SlideShare une entreprise Scribd logo
1  sur  35
Opioids
What are opioids?
•

•

•
•
•

Class of drugs which have morphine
like effects
The effects can be reversed by
naloxone
CNS depressants
Powerful analgesics
Prolonged use results in tolerance,
less effective analgesic properties
Use & Effects of Opioid
Drugs
•

•

•

Opioids that bind to receptors & activate
them are “agonist” drugs (such as morphine
& methadone)
Those that bind to receptors but not activate
them are “antagonists” (naloxone &
naltrexone)
Partial agonists (buprenorphine) bind to the
same receptors but have less of an activation
effect
Harmful Effects
Dependence
 Amenorrhoea
 Infection
Scarring, thrombosis, thrombophlebitis
Cellulitis, abscess
Septicaemia, infective endocarditis,
osteomyelitis
Blood borne viruses - HIV, HCV(90%), HBV
 Overdose-related morbidity symptoms
Hypoxic brain injury
Rhabdomyolysis
 Poly drug and alcohol use highly prevalent

Types of Opioids available
Heroin
 Morphine
 Oxycontin
 Oxycodone
 Methadone
 Buprenorphine

History to take
•
•

•
•
•
•
•

•

Name of the drug/s used
Dose of the drug (no. of injections per
day, dollars spent per day)
Route of administration
Frequency of use
Duration of use
Date and time of last use
Other drugs used ?
Alcohol/ Smoking
Assessing Opioid Use
•

•

•

Heroin dosages estimates are difficult - wide
variations in the concentration & purity of
illicit heroin
Oxycontin – More popular than heroin
Consumption may be recorded as:
The no of injections / day
The no of grams ingested
Dollars spent
Assessing Opioid Use
Approximate guide to a patient’s level of opioid
use:
Low end
= 1 to 2 injections / day, OR
= 0.5 gram heroin or less / day
High end
= 4 + injections / day, OR
= 1-2 grams heroin or more / day
Signs and Symptoms of
opioid intoxication
 Analgesia

 Euphoria
 Miosis

(‘pinned’ pupils)
 Constipation
 Sedation
 Itching, red eyes (histamine release)
 Respiratory depression and reduced cough reflex
 Decreased level of consciousness (‘on the nod’)
 Hypotension/bradycardia
Other Clinical Presentations
General – cachexia,
 CV – Murmurs, Pulse pressure,
stigmata of IE
 GE - CLD / hemetemesis
 Respiratory – LRTI /COPD
 Neuro - Septic Embolus /Discitis
 ID – Cellulitis /Abcesses / Sepsis/
BBV

Investigations
UDS
 Bloods including FBC, LFTs, UEC,
BBV (consent please)
 BAC
 CXR
 ECG

Opioid Overdose
Drowsy
 Decrease in GCS
 Decrease in O2 saturations
 Respiratory depression
 Rx: 400 mcg of Naloxone initially as
test dose and then further 400 mcg of
naloxone
 Consider alternative dx if failure to
respond

Unplanned Withdrawal
•

Patients in hospital, prison or other institutional
care may undergo unplanned opioid withdrawal

•

Patients may not always reveal their opioid use
Withdrawal Syndrome
Opioid

Time after last dose
Sx appear

Duration withdrawal
syndrome (days)

Heroin / Morphine / IV
oxycontin

6 – 24 hours

5 – 10 days

Pethidine

3 – 4 hours

4 – 5 days

Methadone

36 – 48 hours

3 – 6 weeks

Buprenorphine

3 – 5 days

Up to several weeks

Kapanol / MS Contin
(if intravenous)

8 – 24 hours

7 – 10 days

Codeine PO

8 – 24 hours

5 – 10 days
Duration of opioid
withdrawal
•

Following acute withdrawal, protracted,
low-grade symptom of discomfort
(psychological & physical) may last many
months
Signs & Symptoms of Opioid
Withdrawal
Symptoms
Anorexia & nausea
Abdominal pain
Hot & cold flushes
Bone, joint & muscle pain
Insomnia & disturbed sleep
Cramps
Intense craving

Signs
Restlessness
Yawning
Perspiration
Rhinorrhoea
Dilated pupils
Piloerection
Muscle twitching – restless
legs when lying down
Vomiting
Diarrhoea
Course of Opioid withdrawal

NSW Department of Health (2007).
Withdrawal Monitoring
•

Patients should be monitored regularly & this
may include use of a withdrawal scale

•

Frequency of observations should be
determined by the severity of the withdrawal

•

Monitoring should be based on observations,
objective signs & subjective Sx
Withdrawal Scales
•

The Clinical Opiate Withdrawal Scale (COWS)
rates 11 items describing severity of symptoms
from scores of 0 (not present) to > 36 (severe)

•

The COWS is considered a reliable & valid
withdrawal scale
Withdrawal Scales
•

Withdrawal scales do NOT diagnose withdrawal,
but merely guides to the severity of an already
diagnosed withdrawal syndrome

•

Re-evaluate the patient regularly to ensure that
it is opioid withdrawal & not underlying medical
condition, especially if the patient is not
responding well to Rx
Opioid Withdrawal Rx
•

An opioid withdrawal syndrome can be
managed with:
Buprenorphine
Methadone
Symptomatic Meds
Buprenorphine
•

A partial opioid agonist – an opioid analgesic with
both agonist and antagonist properties

•

Available in 2 forms: buprenorphine &
bup/naloxone (Suboxone film)

•

Administered sublingually (tab usually take 5
minutes to dissolve, film adheres within 90 secs)

•

Less respiratory depression than full agonists
Buprenorphine
•

Buprenorphine is the principal Rx option for
managing opioid withdrawal

•

Well suited in the hospital setting

•

Can effectively relieve symptom severity in
opioid withdrawal, meaning that other
symptomatic medication may not be required
Buprenorphine
•

•

•
-

Buprenorphine binds very tightly to opioid
receptors & can displace other opioids
Buprenorphine can precipitate withdrawal
1st doses bup should be delayed for at least 6 hours after heroin & oxy
24 hours after methadone
NB: buprenorphine is NOT to be administered
until withdrawal is evident
Buprenorphine
•

If using a withdrawal scale as part of patient
assessment Rx should not begin until:
A COWS score of a least 8 (representing the
mid point of scale)
Give 2mg buprenorphine (test dose)
If tolerated, can give a further 4-8mg in 1
hour
Pt can have a total of 32mg Day 1 if clinically
indicated
Methadone
“Gold standard” pharmacotherapy for
opioid dependence for over 30 years
 Synthetic opioid with a long half life
 Administered daily
 Dispensed from a clinic, hospital or
registered pharmacy
 Authorised prescribers
 Clients are registered with NSW
Pharmaceutical Services Unit

Methadone to Treat Opioid
W/D
Maximum initiation dose 40mg/d (in
consultation with D&A Team)
 Usually 15mg BD in hospital in initiation
 Usually increase every 3/7’s
 Commonly used in patients who have opioid
analgesia requirements
 D&A Team always offer to link patient in with
community OST
 Patient may or may not want ongoing OST

Symptomatic Mx for Opioid
Withdrawal
Muscles Aches
/ Pains

Paracetamol 1000mg, every 4 hours PRN
(maximum 4000mg in 24 hours OR
Ibuprofen 400mg 6 hourly PRN (if no Hx of
peptic ulcer or gastritis)

Nausea

Metoclopramide 10mg, 4-6 hourly PRN,
reducing to 8th hourly as Sx reduce OR
Prochlorperazine (Stemetil) 5mg, every 4-6
hours PRN, reducing to 8th hourly as Sx
reduce
2nd line Rx for severe nausea/vomiting:
Ondansetron (Zofran) 4-8mg, every 12
hours PRN
Symptomatic Mx for Opioid
Withdrawal
Abdominal
cramps

Hyoscine (buscopan) 20mg, every 6 hours PRN

2nd line Rx for severe gastrointestinal Sx:
Octreotide (sandostatin) 0.05-0.1mg, every 812 hours PRN by subcutaneous injection
(hospital setting only)
Diarrhoea

Kaomagma or loperamide (gastro-stop) 2mg
PRN
Symptomatic Mx for Opioid
Withdrawal
Sleeplessness

Temazepam 10-20mg nocte. Cease dose after
3-5 nights

Agitation /
Anxiety

Diazepam 5mg QID PRN

Restless legs

Diazepam (as above) OR
Baclofen 10-25mg every 8 hours

Sweating,
sedating
agitation

Clonidine 75mcg every 6 hours
Altered tolerance and pain
management
Analgesics should not be withheld unless
medically indicated
 Providing pain relief will not make the patient
more drug dependent
 Methadone patients will not receive pain relief
from their usual daily dose
 First indication of tolerance to opioids is
decreased duration of effect, decreased
analgesia – an involuntary physiological
response

Opioid maintenance treatment
in hospital
Patients who are on methadone or
buprenorphine when admitted to SVH should
remain on their current dose – UNLESS THEY
HAVE MISSED DOSES – PLS RING D&A
• PSU – 9424 5921
 Confirm last dose from the dosing point
 Remove takeaway doses from patient if they
are on their person
 Ensure adequate pain relief is given
 Dosing point will need fax of last dose on D/C
•
Buprenorphine & Pt’s in
Acute Pain….


Standard doses of opioid analgesia are not
likely to be effective in any patient who has
taken buprenorphine within the last 3-4 days



Non opioid analgesia, local anaesthetics
approaches, higher dose opioid prescriptions,
ceasing or increasing bup may be required for
pain relief – Contact D&A & APS
Buprenorphine / methadone
prescribing…
•

In hospital, doctors can prescribe methadone or
buprenorphine as part of management of opioiddependent people

•

Outside hospital, methadone & buprenorphine
may only be used in the treatment of opioid
dependency by authorised medical practitioners
Take Home
Take a good substance use history
 Screen for BBV
 Rx with naloxone in suspected od with
400 mcg x 2
 Rx opioid withdrawal with suboxone or
methadone


Contenu connexe

Tendances (20)

Schizophrenia
Schizophrenia Schizophrenia
Schizophrenia
 
Disorders Stream of Thought
Disorders Stream of ThoughtDisorders Stream of Thought
Disorders Stream of Thought
 
Schizoaffective disorder DSM5
Schizoaffective  disorder DSM5Schizoaffective  disorder DSM5
Schizoaffective disorder DSM5
 
Depression
DepressionDepression
Depression
 
Obsessive compulsive disorder
Obsessive compulsive disorderObsessive compulsive disorder
Obsessive compulsive disorder
 
Schizophrenia ppt
Schizophrenia pptSchizophrenia ppt
Schizophrenia ppt
 
BPAD
BPADBPAD
BPAD
 
Delusion
DelusionDelusion
Delusion
 
MENTAL STATUS EXAMINATION
MENTAL STATUS EXAMINATIONMENTAL STATUS EXAMINATION
MENTAL STATUS EXAMINATION
 
Paranoid schizophrenia
Paranoid schizophreniaParanoid schizophrenia
Paranoid schizophrenia
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Anti-anxiety.pptx
Anti-anxiety.pptxAnti-anxiety.pptx
Anti-anxiety.pptx
 
PSYCHIATRIC HISTORY COLLECTION
PSYCHIATRIC HISTORY COLLECTIONPSYCHIATRIC HISTORY COLLECTION
PSYCHIATRIC HISTORY COLLECTION
 
Antipsychotics.pptx
Antipsychotics.pptxAntipsychotics.pptx
Antipsychotics.pptx
 
Electroconvulsive Therapy
Electroconvulsive TherapyElectroconvulsive Therapy
Electroconvulsive Therapy
 
Delirium
DeliriumDelirium
Delirium
 
Phobias
PhobiasPhobias
Phobias
 
Dementia and delirium
Dementia and deliriumDementia and delirium
Dementia and delirium
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Manic depressive psychosis (bipolar disease)
Manic depressive psychosis (bipolar disease)Manic depressive psychosis (bipolar disease)
Manic depressive psychosis (bipolar disease)
 

En vedette

Common withdrawal syndromes and management
Common withdrawal syndromes and managementCommon withdrawal syndromes and management
Common withdrawal syndromes and managementSCGH ED CME
 
PHARMACOLOGIC TREATMENT OF OPIATE DEPENDENCE
PHARMACOLOGIC TREATMENT OF OPIATE DEPENDENCEPHARMACOLOGIC TREATMENT OF OPIATE DEPENDENCE
PHARMACOLOGIC TREATMENT OF OPIATE DEPENDENCEDr. Paula Jo Colescott
 
Treatment Strategies for Women and Families with Substance Abuse
   Treatment Strategies for Women and Families with  Substance Abuse   Treatment Strategies for Women and Families with  Substance Abuse
Treatment Strategies for Women and Families with Substance AbuseErikaAGoyer
 
Know and Go Friday, May 2016: Addiction Medicine
Know and Go Friday, May 2016: Addiction MedicineKnow and Go Friday, May 2016: Addiction Medicine
Know and Go Friday, May 2016: Addiction MedicineAgnesian HealthCare
 
OPIOID AGONISTS AND ANTAGONISTS
OPIOID AGONISTS AND ANTAGONISTSOPIOID AGONISTS AND ANTAGONISTS
OPIOID AGONISTS AND ANTAGONISTSjamal53
 
Narcotics and non narcotics analgesics
Narcotics and non narcotics analgesicsNarcotics and non narcotics analgesics
Narcotics and non narcotics analgesicsFarazaJaved
 
Cơ bản về cai thở máy
Cơ bản về cai thở máyCơ bản về cai thở máy
Cơ bản về cai thở máyvictor nguyen
 

En vedette (12)

Common withdrawal syndromes and management
Common withdrawal syndromes and managementCommon withdrawal syndromes and management
Common withdrawal syndromes and management
 
PHARMACOLOGIC TREATMENT OF OPIATE DEPENDENCE
PHARMACOLOGIC TREATMENT OF OPIATE DEPENDENCEPHARMACOLOGIC TREATMENT OF OPIATE DEPENDENCE
PHARMACOLOGIC TREATMENT OF OPIATE DEPENDENCE
 
Treatment Strategies for Women and Families with Substance Abuse
   Treatment Strategies for Women and Families with  Substance Abuse   Treatment Strategies for Women and Families with  Substance Abuse
Treatment Strategies for Women and Families with Substance Abuse
 
An Thần, Giãn Cơ Trong Thở Máy
An Thần, Giãn Cơ Trong Thở MáyAn Thần, Giãn Cơ Trong Thở Máy
An Thần, Giãn Cơ Trong Thở Máy
 
Know and Go Friday, May 2016: Addiction Medicine
Know and Go Friday, May 2016: Addiction MedicineKnow and Go Friday, May 2016: Addiction Medicine
Know and Go Friday, May 2016: Addiction Medicine
 
OPIOID AGONISTS AND ANTAGONISTS
OPIOID AGONISTS AND ANTAGONISTSOPIOID AGONISTS AND ANTAGONISTS
OPIOID AGONISTS AND ANTAGONISTS
 
Narcotics and non narcotics analgesics
Narcotics and non narcotics analgesicsNarcotics and non narcotics analgesics
Narcotics and non narcotics analgesics
 
CHUYỂN HÓA NƯỚC - ĐIỆN GIẢI
CHUYỂN HÓA NƯỚC - ĐIỆN GIẢICHUYỂN HÓA NƯỚC - ĐIỆN GIẢI
CHUYỂN HÓA NƯỚC - ĐIỆN GIẢI
 
Hướng dẫn thở máy cho bệnh nhân ards
Hướng dẫn thở máy cho bệnh nhân ardsHướng dẫn thở máy cho bệnh nhân ards
Hướng dẫn thở máy cho bệnh nhân ards
 
Cơ bản về cai thở máy
Cơ bản về cai thở máyCơ bản về cai thở máy
Cơ bản về cai thở máy
 
OPIOID ANALGESICS
OPIOID ANALGESICSOPIOID ANALGESICS
OPIOID ANALGESICS
 
Opioids
OpioidsOpioids
Opioids
 

Similaire à Opioid withdrawal update3[1] (20)

Opioid pain surgery2010
Opioid pain surgery2010Opioid pain surgery2010
Opioid pain surgery2010
 
Sedation
SedationSedation
Sedation
 
Sedation
SedationSedation
Sedation
 
On pain
On painOn pain
On pain
 
Pharma Day1.pptx
Pharma Day1.pptxPharma Day1.pptx
Pharma Day1.pptx
 
Pain management
Pain managementPain management
Pain management
 
pre-medication.pptx
pre-medication.pptxpre-medication.pptx
pre-medication.pptx
 
Opioid analgesics
Opioid analgesicsOpioid analgesics
Opioid analgesics
 
Concious sedation ppt nat
Concious sedation ppt natConcious sedation ppt nat
Concious sedation ppt nat
 
Sedation in icu
Sedation in icuSedation in icu
Sedation in icu
 
Opiate-Analgesics.pptx
Opiate-Analgesics.pptxOpiate-Analgesics.pptx
Opiate-Analgesics.pptx
 
Symptom april2012
Symptom april2012Symptom april2012
Symptom april2012
 
Opioid analgesic
Opioid analgesicOpioid analgesic
Opioid analgesic
 
Post operative pain management
Post operative pain managementPost operative pain management
Post operative pain management
 
Sedation, Analgesia & Delirium.pptx
Sedation, Analgesia & Delirium.pptxSedation, Analgesia & Delirium.pptx
Sedation, Analgesia & Delirium.pptx
 
LUCAS 2019 - Taking the Sting Out of Suboxone
LUCAS 2019 - Taking the Sting Out of SuboxoneLUCAS 2019 - Taking the Sting Out of Suboxone
LUCAS 2019 - Taking the Sting Out of Suboxone
 
Heroine
HeroineHeroine
Heroine
 
Analgesic.ppt
Analgesic.pptAnalgesic.ppt
Analgesic.ppt
 
Iv moderate sedation
Iv moderate sedationIv moderate sedation
Iv moderate sedation
 
Sedation , analgesia & paralysis
Sedation , analgesia & paralysisSedation , analgesia & paralysis
Sedation , analgesia & paralysis
 

Plus de Jeku Jacob

Fwd: Bambury Tutorial on Head and Neck
Fwd: Bambury Tutorial on Head and NeckFwd: Bambury Tutorial on Head and Neck
Fwd: Bambury Tutorial on Head and NeckJeku Jacob
 
Fwd: Post op complications
Fwd: Post op complicationsFwd: Post op complications
Fwd: Post op complicationsJeku Jacob
 
Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)Jeku Jacob
 
Fwd: Head injury Bambury
Fwd: Head injury BamburyFwd: Head injury Bambury
Fwd: Head injury BamburyJeku Jacob
 
Fwd: Diverticular Disease
Fwd: Diverticular DiseaseFwd: Diverticular Disease
Fwd: Diverticular DiseaseJeku Jacob
 
Fwd: Bambury lecture on venous and lymphatic disorders of the limb
Fwd: Bambury lecture on venous and lymphatic disorders of the limbFwd: Bambury lecture on venous and lymphatic disorders of the limb
Fwd: Bambury lecture on venous and lymphatic disorders of the limbJeku Jacob
 
Fwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessmentFwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessmentJeku Jacob
 
Fwd: Bambury tutorial Upper GI Surgery
Fwd: Bambury tutorial Upper GI SurgeryFwd: Bambury tutorial Upper GI Surgery
Fwd: Bambury tutorial Upper GI SurgeryJeku Jacob
 
Fwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. EvoyFwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. EvoyJeku Jacob
 
Fwd: Thyroid Surgery (Cormac Joyce)
Fwd: Thyroid Surgery (Cormac Joyce)Fwd: Thyroid Surgery (Cormac Joyce)
Fwd: Thyroid Surgery (Cormac Joyce)Jeku Jacob
 
Fwd: Cardiothoracic surgery Bambury
Fwd: Cardiothoracic surgery BamburyFwd: Cardiothoracic surgery Bambury
Fwd: Cardiothoracic surgery BamburyJeku Jacob
 
Upper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyUpper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyJeku Jacob
 
Fwd: Wound Healing
Fwd: Wound HealingFwd: Wound Healing
Fwd: Wound HealingJeku Jacob
 

Plus de Jeku Jacob (17)

Bzd 2012[1]
Bzd 2012[1]Bzd 2012[1]
Bzd 2012[1]
 
Etoh[1]
Etoh[1]Etoh[1]
Etoh[1]
 
Fwd: Bambury Tutorial on Head and Neck
Fwd: Bambury Tutorial on Head and NeckFwd: Bambury Tutorial on Head and Neck
Fwd: Bambury Tutorial on Head and Neck
 
Fwd: lecture
Fwd: lectureFwd: lecture
Fwd: lecture
 
Fwd: Post op complications
Fwd: Post op complicationsFwd: Post op complications
Fwd: Post op complications
 
Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)
 
Fwd: Head injury Bambury
Fwd: Head injury BamburyFwd: Head injury Bambury
Fwd: Head injury Bambury
 
Fwd: Jaundice
Fwd: JaundiceFwd: Jaundice
Fwd: Jaundice
 
Fwd: Diverticular Disease
Fwd: Diverticular DiseaseFwd: Diverticular Disease
Fwd: Diverticular Disease
 
Fwd: Bambury lecture on venous and lymphatic disorders of the limb
Fwd: Bambury lecture on venous and lymphatic disorders of the limbFwd: Bambury lecture on venous and lymphatic disorders of the limb
Fwd: Bambury lecture on venous and lymphatic disorders of the limb
 
Fwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessmentFwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessment
 
Fwd: Bambury tutorial Upper GI Surgery
Fwd: Bambury tutorial Upper GI SurgeryFwd: Bambury tutorial Upper GI Surgery
Fwd: Bambury tutorial Upper GI Surgery
 
Fwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. EvoyFwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. Evoy
 
Fwd: Thyroid Surgery (Cormac Joyce)
Fwd: Thyroid Surgery (Cormac Joyce)Fwd: Thyroid Surgery (Cormac Joyce)
Fwd: Thyroid Surgery (Cormac Joyce)
 
Fwd: Cardiothoracic surgery Bambury
Fwd: Cardiothoracic surgery BamburyFwd: Cardiothoracic surgery Bambury
Fwd: Cardiothoracic surgery Bambury
 
Upper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyUpper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) Bambury
 
Fwd: Wound Healing
Fwd: Wound HealingFwd: Wound Healing
Fwd: Wound Healing
 

Opioid withdrawal update3[1]

  • 2. What are opioids? • • • • • Class of drugs which have morphine like effects The effects can be reversed by naloxone CNS depressants Powerful analgesics Prolonged use results in tolerance, less effective analgesic properties
  • 3. Use & Effects of Opioid Drugs • • • Opioids that bind to receptors & activate them are “agonist” drugs (such as morphine & methadone) Those that bind to receptors but not activate them are “antagonists” (naloxone & naltrexone) Partial agonists (buprenorphine) bind to the same receptors but have less of an activation effect
  • 4. Harmful Effects Dependence  Amenorrhoea  Infection Scarring, thrombosis, thrombophlebitis Cellulitis, abscess Septicaemia, infective endocarditis, osteomyelitis Blood borne viruses - HIV, HCV(90%), HBV  Overdose-related morbidity symptoms Hypoxic brain injury Rhabdomyolysis  Poly drug and alcohol use highly prevalent 
  • 5. Types of Opioids available Heroin  Morphine  Oxycontin  Oxycodone  Methadone  Buprenorphine 
  • 6. History to take • • • • • • • • Name of the drug/s used Dose of the drug (no. of injections per day, dollars spent per day) Route of administration Frequency of use Duration of use Date and time of last use Other drugs used ? Alcohol/ Smoking
  • 7. Assessing Opioid Use • • • Heroin dosages estimates are difficult - wide variations in the concentration & purity of illicit heroin Oxycontin – More popular than heroin Consumption may be recorded as: The no of injections / day The no of grams ingested Dollars spent
  • 8. Assessing Opioid Use Approximate guide to a patient’s level of opioid use: Low end = 1 to 2 injections / day, OR = 0.5 gram heroin or less / day High end = 4 + injections / day, OR = 1-2 grams heroin or more / day
  • 9. Signs and Symptoms of opioid intoxication  Analgesia  Euphoria  Miosis (‘pinned’ pupils)  Constipation  Sedation  Itching, red eyes (histamine release)  Respiratory depression and reduced cough reflex  Decreased level of consciousness (‘on the nod’)  Hypotension/bradycardia
  • 10. Other Clinical Presentations General – cachexia,  CV – Murmurs, Pulse pressure, stigmata of IE  GE - CLD / hemetemesis  Respiratory – LRTI /COPD  Neuro - Septic Embolus /Discitis  ID – Cellulitis /Abcesses / Sepsis/ BBV 
  • 11. Investigations UDS  Bloods including FBC, LFTs, UEC, BBV (consent please)  BAC  CXR  ECG 
  • 12. Opioid Overdose Drowsy  Decrease in GCS  Decrease in O2 saturations  Respiratory depression  Rx: 400 mcg of Naloxone initially as test dose and then further 400 mcg of naloxone  Consider alternative dx if failure to respond 
  • 13. Unplanned Withdrawal • Patients in hospital, prison or other institutional care may undergo unplanned opioid withdrawal • Patients may not always reveal their opioid use
  • 14. Withdrawal Syndrome Opioid Time after last dose Sx appear Duration withdrawal syndrome (days) Heroin / Morphine / IV oxycontin 6 – 24 hours 5 – 10 days Pethidine 3 – 4 hours 4 – 5 days Methadone 36 – 48 hours 3 – 6 weeks Buprenorphine 3 – 5 days Up to several weeks Kapanol / MS Contin (if intravenous) 8 – 24 hours 7 – 10 days Codeine PO 8 – 24 hours 5 – 10 days
  • 15. Duration of opioid withdrawal • Following acute withdrawal, protracted, low-grade symptom of discomfort (psychological & physical) may last many months
  • 16. Signs & Symptoms of Opioid Withdrawal Symptoms Anorexia & nausea Abdominal pain Hot & cold flushes Bone, joint & muscle pain Insomnia & disturbed sleep Cramps Intense craving Signs Restlessness Yawning Perspiration Rhinorrhoea Dilated pupils Piloerection Muscle twitching – restless legs when lying down Vomiting Diarrhoea
  • 17. Course of Opioid withdrawal NSW Department of Health (2007).
  • 18. Withdrawal Monitoring • Patients should be monitored regularly & this may include use of a withdrawal scale • Frequency of observations should be determined by the severity of the withdrawal • Monitoring should be based on observations, objective signs & subjective Sx
  • 19. Withdrawal Scales • The Clinical Opiate Withdrawal Scale (COWS) rates 11 items describing severity of symptoms from scores of 0 (not present) to > 36 (severe) • The COWS is considered a reliable & valid withdrawal scale
  • 20. Withdrawal Scales • Withdrawal scales do NOT diagnose withdrawal, but merely guides to the severity of an already diagnosed withdrawal syndrome • Re-evaluate the patient regularly to ensure that it is opioid withdrawal & not underlying medical condition, especially if the patient is not responding well to Rx
  • 21. Opioid Withdrawal Rx • An opioid withdrawal syndrome can be managed with: Buprenorphine Methadone Symptomatic Meds
  • 22. Buprenorphine • A partial opioid agonist – an opioid analgesic with both agonist and antagonist properties • Available in 2 forms: buprenorphine & bup/naloxone (Suboxone film) • Administered sublingually (tab usually take 5 minutes to dissolve, film adheres within 90 secs) • Less respiratory depression than full agonists
  • 23. Buprenorphine • Buprenorphine is the principal Rx option for managing opioid withdrawal • Well suited in the hospital setting • Can effectively relieve symptom severity in opioid withdrawal, meaning that other symptomatic medication may not be required
  • 24. Buprenorphine • • • - Buprenorphine binds very tightly to opioid receptors & can displace other opioids Buprenorphine can precipitate withdrawal 1st doses bup should be delayed for at least 6 hours after heroin & oxy 24 hours after methadone NB: buprenorphine is NOT to be administered until withdrawal is evident
  • 25. Buprenorphine • If using a withdrawal scale as part of patient assessment Rx should not begin until: A COWS score of a least 8 (representing the mid point of scale) Give 2mg buprenorphine (test dose) If tolerated, can give a further 4-8mg in 1 hour Pt can have a total of 32mg Day 1 if clinically indicated
  • 26. Methadone “Gold standard” pharmacotherapy for opioid dependence for over 30 years  Synthetic opioid with a long half life  Administered daily  Dispensed from a clinic, hospital or registered pharmacy  Authorised prescribers  Clients are registered with NSW Pharmaceutical Services Unit 
  • 27. Methadone to Treat Opioid W/D Maximum initiation dose 40mg/d (in consultation with D&A Team)  Usually 15mg BD in hospital in initiation  Usually increase every 3/7’s  Commonly used in patients who have opioid analgesia requirements  D&A Team always offer to link patient in with community OST  Patient may or may not want ongoing OST 
  • 28. Symptomatic Mx for Opioid Withdrawal Muscles Aches / Pains Paracetamol 1000mg, every 4 hours PRN (maximum 4000mg in 24 hours OR Ibuprofen 400mg 6 hourly PRN (if no Hx of peptic ulcer or gastritis) Nausea Metoclopramide 10mg, 4-6 hourly PRN, reducing to 8th hourly as Sx reduce OR Prochlorperazine (Stemetil) 5mg, every 4-6 hours PRN, reducing to 8th hourly as Sx reduce 2nd line Rx for severe nausea/vomiting: Ondansetron (Zofran) 4-8mg, every 12 hours PRN
  • 29. Symptomatic Mx for Opioid Withdrawal Abdominal cramps Hyoscine (buscopan) 20mg, every 6 hours PRN 2nd line Rx for severe gastrointestinal Sx: Octreotide (sandostatin) 0.05-0.1mg, every 812 hours PRN by subcutaneous injection (hospital setting only) Diarrhoea Kaomagma or loperamide (gastro-stop) 2mg PRN
  • 30. Symptomatic Mx for Opioid Withdrawal Sleeplessness Temazepam 10-20mg nocte. Cease dose after 3-5 nights Agitation / Anxiety Diazepam 5mg QID PRN Restless legs Diazepam (as above) OR Baclofen 10-25mg every 8 hours Sweating, sedating agitation Clonidine 75mcg every 6 hours
  • 31. Altered tolerance and pain management Analgesics should not be withheld unless medically indicated  Providing pain relief will not make the patient more drug dependent  Methadone patients will not receive pain relief from their usual daily dose  First indication of tolerance to opioids is decreased duration of effect, decreased analgesia – an involuntary physiological response 
  • 32. Opioid maintenance treatment in hospital Patients who are on methadone or buprenorphine when admitted to SVH should remain on their current dose – UNLESS THEY HAVE MISSED DOSES – PLS RING D&A • PSU – 9424 5921  Confirm last dose from the dosing point  Remove takeaway doses from patient if they are on their person  Ensure adequate pain relief is given  Dosing point will need fax of last dose on D/C •
  • 33. Buprenorphine & Pt’s in Acute Pain….  Standard doses of opioid analgesia are not likely to be effective in any patient who has taken buprenorphine within the last 3-4 days  Non opioid analgesia, local anaesthetics approaches, higher dose opioid prescriptions, ceasing or increasing bup may be required for pain relief – Contact D&A & APS
  • 34. Buprenorphine / methadone prescribing… • In hospital, doctors can prescribe methadone or buprenorphine as part of management of opioiddependent people • Outside hospital, methadone & buprenorphine may only be used in the treatment of opioid dependency by authorised medical practitioners
  • 35. Take Home Take a good substance use history  Screen for BBV  Rx with naloxone in suspected od with 400 mcg x 2  Rx opioid withdrawal with suboxone or methadone 